13F-HR filed by Endurant Capital Management LP
Endurant Capital Management LP filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 43 holding rows worth $111,347,011.
- Accession
- 0001633055-23-000008
- Filer
- CIK 1633055
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 43 entries on the cover page, a total value of $111,347,011 stated on the cover page (in dollars after the unit check, H1), rows summing to $111,347,011 with VALUE read as dollars as filed, 13F file number 028-16634. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 179,568 | $15,888,177 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 13,849 | $7,009,948 | dollars as filed | |
| BRUKER CORP | 116794108 | COM | 111,276 | $6,932,495 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 96,444 | $6,531,188 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 13,501 | $5,878,605 | dollars as filed | |
| AVANTOR INC COM | 05352A100 | Stock | 226,877 | $4,782,567 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 44,384 | $4,569,333 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 9,108 | $4,477,766 | dollars as filed | |
| CONMED CORP COM | 207410101 | Stock | 41,984 | $4,234,086 | dollars as filed | |
| THE COOPER COMPANIES | 216648402 | COM NEW | 11,533 | $3,667,609 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 6,584 | $3,203,248 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 71,044 | $2,930,565 | dollars as filed | |
| SABRA HEALTH CARE REIT INC COM | 78573L106 | REIT | 203,792 | $2,840,860 | dollars as filed | |
| OMEGA HEALTHCARE INVS INC COM | 681936100 | REIT | 80,070 | $2,655,121 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 47,893 | $2,528,750 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 70,364 | $2,251,648 | dollars as filed | |
| CENCORA INC COM | 03073E105 | Stock | 11,606 | $2,088,732 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 7,547 | $2,062,369 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 79,471 | $2,006,643 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 17,479 | $1,961,493 | dollars as filed | |
| QUIDELORTHO CORP COM | 219798105 | Stock | 26,747 | $1,953,601 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 20,694 | $1,930,750 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 27,151 | $1,788,979 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 18,040 | $1,747,174 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 6,083 | $1,740,164 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 8,878 | $1,415,952 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 82,153 | $1,268,442 | dollars as filed | |
| HOLOGIC INC | 436440101 | COM | 17,750 | $1,231,850 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 353,707 | $1,110,640 | dollars as filed | |
| AZENTA INC | 114340102 | COM | 19,422 | $974,790 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 47,649 | $846,723 | dollars as filed | |
| ADAPTHEALTH CORP | 00653Q102 | COMMON STOCK | 89,937 | $818,427 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 11,254 | $786,542 | dollars as filed | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 3,946 | $776,376 | dollars as filed | |
| BLUEBIRD BIO INC | 09609G100 | COM | 251,785 | $765,426 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 58,573 | $723,377 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 18,458 | $641,046 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 14,158 | $507,989 | dollars as filed | |
| GOODRX HLDGS INC | 38246G108 | COM CL A | 87,290 | $491,443 | dollars as filed | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 453,314 | $480,513 | dollars as filed | |
| ISHARES TR | 464287432 | 20 YR TR BD ETF | 3,400 | $301,546 | dollars as filed | |
| ENVISTA HOLDINGS CORPORATION | 29415F104 | COM | 10,787 | $300,742 | dollars as filed | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 311,944 | $243,316 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001633055-23-000008 | this filing | 2023-11-14 | acceptance time not in the bulk data set |